Single Injection of Cross-Linked Hyaluronate in Knee Osteoarthritis: A 52-Week Double-Blind Randomized Controlled Trial
暂无分享,去创建一个
L. Kuo | I. Jou | W. Su | Chung-Yi Li | Po-Ting Wu | P.-Y. Ko | Chia-Lung Li | Chung‐Yi Li
[1] Seulbi Lee,et al. Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment. , 2021, Biomaterials.
[2] D. Haupenthal,et al. Intra‐articular treatment with hyaluronic acid associated with gold nanoparticles in a mechanical osteoarthritis model in Wistar rats , 2021, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[3] F. Lin,et al. Hyaluronic Acid Loaded with Cerium Oxide Nanoparticles as Antioxidant in Hydrogen Peroxide Induced Chondrocytes Injury: An In Vitro Osteoarthritis Model , 2020, Molecules.
[4] Ilker S. Bayer. Hyaluronic Acid and Controlled Release: A Review , 2020, Molecules.
[5] M. Samiei,et al. The Potential Applications of Hyaluronic Acid Hydrogels in Biomedicine , 2019, Drug Research.
[6] E. Kon,et al. Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial , 2018, The American journal of sports medicine.
[7] S. Petterson,et al. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial , 2018, Knee Surgery, Sports Traumatology, Arthroscopy.
[8] R. Leighton,et al. Systematic clinical evidence review of NASHA (Durolane hyaluronic acid) for the treatment of knee osteoarthritis , 2018, Open access rheumatology : research and reviews.
[9] Huey-Shyan Lin,et al. Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety , 2017, The Journal of bone and joint surgery. American volume.
[10] M. H. Santana,et al. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee , 2016, Journal of stem cells & regenerative medicine.
[11] R. Altman,et al. Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee , 2016, The American journal of sports medicine.
[12] J. Reginster,et al. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. , 2016, Seminars in arthritis and rheumatism.
[13] Brian J Cole,et al. Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee: A Systematic Review of Overlapping Meta-analyses. , 2015, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[14] J. Jerosch,et al. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. , 2015, Seminars in arthritis and rheumatism.
[15] J. García-Sancho,et al. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial , 2015, Transplantation.
[16] S Lohmander,et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. , 2014, Osteoarthritis and cartilage.
[17] G. Orive,et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. , 2013, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[18] Greg A. Brown. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. , 2013, The Journal of the American Academy of Orthopaedic Surgeons.
[19] C. Cooper,et al. Epidemiology and burden of osteoarthritis. , 2013, British medical bulletin.
[20] L. Kuo,et al. Pain in patients with equal radiographic grades of osteoarthritis in both knees: the value of gray scale ultrasound. , 2012, Osteoarthritis and cartilage.
[21] Gordon Guyatt,et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee , 2012, Arthritis care & research.
[22] D. Uebelhart,et al. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study. , 2011, Osteoarthritis and cartilage.
[23] Raveendhara R. Bannuru,et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. , 2010, Osteoarthritis and cartilage.
[24] F. Luyten,et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial , 2009, Annals of the rheumatic diseases.
[25] N. Bellamy,et al. Viscosupplementation for the treatment of osteoarthritis of the knee. , 2006, The Cochrane database of systematic reviews.
[26] M. Dougados,et al. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis , 2005, Annals of the rheumatic diseases.
[27] T. Schnitzer,et al. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. , 2004, Osteoarthritis and cartilage.
[28] R. Coutts,et al. Viscosupplementation for osteoarthritis of the knee. , 2004, Orthopedics.
[29] E. Vignon,et al. Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. , 2003, Joint, bone, spine : revue du rhumatisme.
[30] A. Davis,et al. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. , 2001, Arthritis and rheumatism.
[31] H. Bliddal,et al. Guidance by ultrasound of intra-articular injections in the knee and hip joints. , 2001, Osteoarthritis and cartilage.
[32] P. Burton,et al. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. , 1998, Statistics in medicine.
[33] W. Olszynski,et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. , 1996, The Journal of rheumatology.
[34] Diane Podsiadlo,et al. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.
[35] R. Moskowitz,et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.
[36] R W Bohannon,et al. Decrease in timed balance test scores with aging. , 1984, Physical therapy.
[37] M. Yeh,et al. Intra-articular Injection of Platelet-Rich Plasma Is Superior to Hyaluronic Acid or Saline Solution in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized, Double-Blind, Triple-Parallel, Placebo-Controlled Clinical Trial. , 2019, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[38] N. Arden,et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. , 2014, Osteoarthritis and cartilage.